Yuping Gong

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 26

Top Topics

Acute Myeloid Leukemia

Multiple Myeloma

Top Venues

Cancer medicine

British journal of haematology

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Xiang Liu, Xinai Gan, Jing Xu, Yutong Wang, Jie Huang, Xu He, Yan Li, Yuping Gong, Bing Peng, Ting Niu
COVID-19 vaccination in splenectomized patients with immune thrombocytopenia-Response. British journal of haematology (2024)
Xiang Liu, Xinai Gan, Jing Xu, Yutong Wang, Jie Huang, Xu He, Yan Li, Yuping Gong, Bing Peng, Ting Niu
Protective effects of COVID-19 vaccination in splenectomized patients with immune thrombocytopenia. British journal of haematology 204 (6) (2024)
Xiang Liu, Xinai Gan, Jing Xu, Yutong Wang, Jie Huang, Xu He, Yan Li, Yuping Gong, Bing Peng, Ting Niu
COVID-19 vaccination in splenectomized patients with immune thrombocytopenia-Response. British journal of haematology 205 (2) (2024)
Xiang Liu, Xinai Gan, Jing Xu, Yutong Wang, Jie Huang, Xu He, Yan Li, Yuping Gong, Bing Peng, Ting Niu
Protective effects of COVID-19 vaccination in splenectomized patients with immune thrombocytopenia. British journal of haematology (2024)
Wu Ye, Mingzhu Ma, Xia Wu, Jili Deng, Xiaoyan Liu, Xue Zheng, Yuping Gong
Prognostic significance of KMT2A- PTD in patients with acute myeloid leukaemia: a systematic review and meta-analysis. BMJ open 13 (2) (2023)
Liqing Yang, Xiaoyu Wei, Yuping Gong
Prognosis and risk factors for ASXL1 mutations in patients with newly diagnosed acute myeloid leukemia and myelodysplastic syndrome. Cancer medicine (2023)
Wu Ye, Mingzhu Ma, Xia Wu, Jili Deng, Xiaoyan Liu, Xue Zheng, Yuping Gong
Prognostic significance of KMT2A- PTD in patients with acute myeloid leukaemia: a systematic review and meta-analysis. BMJ open 13 (2) (2023)
Wu Ye, Mingzhu Ma, Xia Wu, Jili Deng, Xiaoyan Liu, Xue Zheng, Yuping Gong
Prognostic significance of KMT2A- PTD in patients with acute myeloid leukaemia: a systematic review and meta-analysis. BMJ open 13 (2) (2023)
Liqing Yang, Xiaoyu Wei, Yuping Gong
Prognosis and risk factors for ASXL1 mutations in patients with newly diagnosed acute myeloid leukemia and myelodysplastic syndrome. Cancer medicine (2023)
Liqing Yang, Xiaoyu Wei, Yuping Gong
Prognosis and risk factors for ASXL1 mutations in patients with newly diagnosed acute myeloid leukemia and myelodysplastic syndrome. Cancer medicine 13 (1) (2023)
Liqing Yang, Xiaoyu Wei, Yuping Gong
Prognosis and risk factors for ASXL1 mutations in patients with newly diagnosed acute myeloid leukemia and myelodysplastic syndrome. Cancer medicine (2023)
Wu Ye, Mingzhu Ma, Xia Wu, Jili Deng, Xiaoyan Liu, Xue Zheng, Yuping Gong
Prognostic significance of KMT2A- PTD in patients with acute myeloid leukaemia: a systematic review and meta-analysis. BMJ open 13 (2) (2023)
Wu Ye, Mingzhu Ma, Xia Wu, Jili Deng, Xiaoyan Liu, Xue Zheng, Yuping Gong
Prognostic significance of KMT2A- PTD in patients with acute myeloid leukaemia: a systematic review and meta-analysis. BMJ open 13 (2) (2023)
Liqing Yang, Huiying Shu, Min Zhou, Yuping Gong
Literature review on genotype-phenotype correlation in patients with hereditary spherocytosis. Clinical genetics 102 (6) (2022)
Xia Wu, Jili Deng, Nanchen Zhang, Xiaoyan Liu, Xue Zheng, Tianyou Yan, Wu Ye, Yuping Gong
Pedigree investigation, clinical characteristics, and prognosis analysis of haematological disease patients with germline TET2 mutation. BMC cancer 22 (1) (2022)
Shutan Li, Duanzhong Zhang, Lihua Yang, Chunlan Huang, Ting Niu, Yuping Gong
Comparison between ixazomib+cyclophosphamide+dexamethasone regimen and ixazomib+dexamethasone regimen for elderly and frail patients having newly diagnosed multiple myeloma. Cancer medicine (2022)
Xue Zheng, Yuping Gong
Functions of RNA N6-methyladenosine modification in acute myeloid leukemia. Biomarker research 9 (1) (2021)
Wu Ye, Xia Wu, Xiaoyan Liu, Xue Zheng, Jili Deng, Yuping Gong
Comparison of monoclonal antibodies targeting CD38, SLAMF7 and PD-1/PD-L1 in combination with Bortezomib/Immunomodulators plus dexamethasone/prednisone for the treatment of multiple myeloma: an indirect-comparison Meta-analysis of randomised controlled trials. BMC cancer 21 (1) (2021)
Jili Deng, Xia Wu, Yantao Ling, Xiaoyan Liu, Xue Zheng, Wu Ye, Yuping Gong
The prognostic impact of variant allele frequency (VAF) in TP53 mutant patients with MDS: A systematic review and meta-analysis. European journal of haematology 105 (5) (2020)
Xia Wu, Dongxia Luo, Yaling Liu, Yilan Zeng, Yuping Gong
Continuous thrombocytopenia after SARS-CoV-2 nucleic acid negative in a non-severe COVID-19 patient for several months. BMC infectious diseases 20 (1) (2020)
Duolan Naren, Tianyou Yan, Yuping Gong, Jingcao Huang, Dan Zhang, Lina Sang, Xue Zheng, Yarong Li
High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m6A methylation of MYC mRNA. Journal of cancer research and clinical oncology 147 (1) (2020)
Tianyou Yan, Duolan Naren, Yuping Gong
Positive expression of PAX7 indicates poor prognosis of pediatric and adolescent AML patients. Expert review of hematology 13 (3) (2020)
Xia Wu, Huifang Wang, Jili Deng, Xue Zheng, Yantao Ling, Yuping Gong
Prognostic significance of the EVI1 gene expression in patients with acute myeloid leukemia: a meta-analysis. Annals of hematology 98 (11) (2019)
Huifang Wang, Nanchen Zhang, Xia Wu, Xue Zheng, Yantao Ling, Yuping Gong
Prognostic value of U2AF1 mutant in patients with de novo myelodysplastic syndromes: a meta-analysis. Annals of hematology 98 (12) (2019)
Hongbing Ma, Iyer Swaminathan Padmanabhan, Simrit Parmar, Yuping Gong
Targeting CLL-1 for acute myeloid leukemia therapy. Journal of hematology & oncology 12 (1) (2019)
Xiaoyan Liu, Yuping Gong
Isocitrate dehydrogenase inhibitors in acute myeloid leukemia. Biomarker research 7 (2019)